Home > Drug Search >
  • Targets: Sarco-endoplasmic reticulum Ca2 -ATPase (SERCA)
  •   > 
Drug Filter
Status:
Approved (4) Phase Ⅱ (10) Phase Ⅰ (5)
Clinical Stage:
Pending (2) Active (6) Discontinued (7)
Company:
Gilead (2) National Cancer Institute (1) Pfizer (3) Sanofi (1) Vertex (1) Unknown (2) Velacor Therapeutics (1) Mirati Therapeutics (1) Achillion Pharmaceutical (1) Aslan (1) Inspyr Therapeutics (1) Zealand Pharma (1) Lixte (1) Upsher-Smith Laboratories (1) 爱博新药研发(上海) (1) Boehringer Ingelheim (1) Bristol-Myers Squibb (1)
Indication:
Alzheimer's disease (AD) (1) Atrial fibrillation (1) Breast cancer (1) ROS1-positive non-small cell lung cancer(NSCLC) (1) Epilepsy/Seizures (1) Gastric cancer (1) Glioblastoma multiforme (1) HCV infection (6) Hepatocellular carcinoma (HCC) (1) Migraine (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (2) Solid tumours (3) Ulcerative colitis (1) Malaria (2) Ventricular tachycardia (1)
Country:
Aprv. Year:
1995 (1) 2011 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top